[HTML][HTML] Leveraging human genetics to identify potential new treatments for fatty liver disease
Fatty liver disease (FLD), including its more severe pathologies, namely steatohepatitis,
hepatocarcinoma, and cirrhosis, is the most common cause of chronic liver disease …
hepatocarcinoma, and cirrhosis, is the most common cause of chronic liver disease …
[PDF][PDF] Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
S Romeo, A Sanyal, L Valenti - Cell Metabolism, 2020 - sochob.cl
Fatty liver disease (FLD), including its more severe pathologies, namely steatohepatitis,
hepatocarcinoma, and cirrhosis, is the most common cause of chronic liver disease …
hepatocarcinoma, and cirrhosis, is the most common cause of chronic liver disease …
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease.
S Romeo, A Sanyal, L Valenti - Cell Metabolism, 2020 - europepmc.org
Fatty liver disease (FLD), including its more severe pathologies, namely steatohepatitis,
hepatocarcinoma, and cirrhosis, is the most common cause of chronic liver disease …
hepatocarcinoma, and cirrhosis, is the most common cause of chronic liver disease …
[HTML][HTML] Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
S Romeo, A Sanyal, L Valenti - Cell Metabolism, 2020 - cell.com
Fatty liver disease (FLD), including its more severe pathologies, namely steatohepatitis,
hepatocarcinoma, and cirrhosis, is the most common cause of chronic liver disease …
hepatocarcinoma, and cirrhosis, is the most common cause of chronic liver disease …
[引用][C] Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
S Romeo, A Sanyal, L Valenti - Cell Metabolism, 2020 - cir.nii.ac.jp
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
[HTML][HTML] Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
S Romeo, A Sanyal, L Valenti - Cell Metabolism, 2020 - Elsevier
Fatty liver disease (FLD), including its more severe pathologies, namely steatohepatitis,
hepatocarcinoma, and cirrhosis, is the most common cause of chronic liver disease …
hepatocarcinoma, and cirrhosis, is the most common cause of chronic liver disease …
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
S Romeo, A Sanyal, L Valenti - Cell metabolism, 2020 - pubmed.ncbi.nlm.nih.gov
Fatty liver disease (FLD), including its more severe pathologies, namely steatohepatitis,
hepatocarcinoma, and cirrhosis, is the most common cause of chronic liver disease …
hepatocarcinoma, and cirrhosis, is the most common cause of chronic liver disease …
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
S Romeo, A Sanyal, L Valenti - CELL METABOLISM, 2020 - air.unimi.it
Fatty liver disease (FLD), including its more severe pathologies, namely steatohepatitis,
hepatocarcinoma, and cirrhosis, is the most common cause of chronic liver disease …
hepatocarcinoma, and cirrhosis, is the most common cause of chronic liver disease …